Collectively, these findings reveal that PRDM16 is a novel suppressor of ferroptosis and that targeting PRDM16 using PLGA-encapsulated formononetin represents a new therapeutic strategy for sepsis-induced multiple organ injury, including AKI. The gene discussed is PRDM16; the disease is Sepsis.